在患有阿片类药物使用障碍的个体中,弹性表现型和心理功能
Suky Martinez1, Albert Garcia-Romeu2, Freymon Perez1
1Division on Substance Use Disorders, Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons and New York State Psychiatric Institute, New York, New York, USA.
Substance use & misuse
|September 27, 2023
概括
患有阿片类药物使用障碍 (OUD) 的人表现出与人格特征相关的明显的性表型. 更高的弹性与更好的心理功能相关,这表明弹性是OUD的关键干预目标.
科学领域:
- 精神病学是一个精神病学.
- 心理学 心理学 心理学
- 遗传学 遗传学 是一个
背景情况:
- 阿片类药物使用障碍 (OUD) 是复杂的,缺乏深层次的表型,特别是在性等心理因素方面.
- 弹性和五因素人格模型 (FFM) 是可能影响OUD的关键心理构造.
- 缺乏研究的人群,例如非洲血统的人群,需要在OUD研究中进行专注的调查.
研究的目的:
- 研究OUD患者的特征弹性和FFM之间的关系.
- 探索FFM和特征性是否定义了与OUD中心理功能相关的特定表型.
- 为了确定OUD干预的潜在心理目标.
主要方法:
- 一项涉及72名非洲血统参与者进行的表观遗传学研究的二次分析,这些参与者符合OUD的DSM-5标准.
- 评估人格特征 (FFM),特征性,药物使用史和心理功能 (抑郁,焦虑,压力).
- 统计分析包括线性回归和集群分析,以确定弹性表型.
主要成果:
- 在性和FFM之间发现了显著的关系 (R2 = 0.56,p<.001).
- 两个不同的弹性集群出现了:一个具有较低的弹性 (n=33) 和一个具有更高的弹性 (n=35).
- 高弹性群体表现出更高的FFM特征 (外向,开放,愉悦,良心) 和较低的神经性,以及抑郁,焦虑和压力症状的减少.
结论:
- 结果表明FFM与OUD个体的特征弹性之间存在关联.
- 确定了两个不同的弹性现象型,更高的弹性与更好的心理福祉有关.
- 弹性成为临床上重要的因素,也是OUD治疗中治疗干预的潜在目标.
更多相关视频
相关概念视频
Substance Use Disorders Affecting Sleep
188
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
188
Drug Abuse and Addiction: Pharmacological Phenomena
501
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
501
Stress and Mental Health
176
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
176
Analgesia and Pain Management
649
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
649
Drug Dependence
1.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.0K
Opioid Receptors: Overview
984
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
984


